Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046

JOHNSON & JOHNSON (JNJ)

284
Delayed Quote. Delayed Nyse - 04/24 04:00:55 pm
101.08 USD   +0.62%
04/24 JOHNSON & JOHNS : to Host Pharmaceutical Business Review
04/23 JOHNSON & JOHNS : hikes quarterly dividend 7 pct. at annual meeting,..
04/23DJJOHNSON & JOHNS : Lifts Dividend
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Johnson & Johnson : to Host Pharmaceutical Business Review

04/24/2015 | 05:27am US/Eastern

NEW BRUNSWICK, NJ - Johnson & Johnson (NYSE: JNJ) will host a review of its Pharmaceutical business for the investment community beginning at 8:30 a.m. (Eastern Time) on Wednesday, May 20, 2015 at the Hyatt Regency Hotel in New Brunswick, New Jersey and ending at approximately 3:00 p.m.

Paul Stoffels, M.D., Worldwide Chairman Pharmaceuticals, and Chief Scientific Officer and Joaquin Duato, Worldwide Chairman, Pharmaceuticals will host the meeting. Dominic Caruso, Vice President, Finance and Chief Financial Officer will provide opening remarks. The meeting will feature presentations from the therapeutic area leaders within the Pharmaceutical Research and Development organization.

The agenda for the day will be posted on the Investor Relations website on approximately May 13th.

Investors and other interested parties may access this meeting by visiting the Company's website at www.investor.jnj.com for a simultaneous webcast of the presentations.

A replay and podcast will be available shortly after the live webcast through www.investor.jnj.com.

###

Press Contacts:

Ernie Knewitz

(732) 524-6623

(917) 697-2318 (M)

Amy Jo Meyer

(732) 524-6678

(908) 616-6250 (M)

Investor Contacts:

Louise Mehrotra

(732) 524-6491

Lesley Fishman

(732) 524-3922

.

(c) 2015 M2 COMMUNICATIONS, source M2 PressWIRE

React to this article
Latest news on JOHNSON & JOHNSON
04/24 JOHNSON & JOHNSON : to Host Pharmaceutical Business Review
04/23 JOHNSON & JOHNSON : hikes quarterly dividend 7 pct. at annual meeting, cites str..
04/23DJJOHNSON & JOHNSON : Lifts Dividend
04/23DJJOHNSON & JOHNSON : Lifts Dividend
04/23 JOHNSON & JOHNSON : hikes quarterly dividend 7 percent
04/23 JOHNSON & JOHNSON : Announces Dividend Increase of 7.1%
04/22 JOHNSON & JOHNSON : Investigators from Johnson & Johnson Have Reported New Data ..
04/22 JOHNSON & JOHNSON : Reports 2015 First-Quarter Results:
04/21DJHealth-Care Startups Raise Record $3.89 Billion in Venture Capital in First Q..
04/21DJU.S. Firms Urge China to Improve Conditions
Advertisement
Chart
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF